Why Moderna Stock Surged Today
Shares of Moderna (NASDAQ:MRNA) jumped more than 14% on Friday, following reports of a major new cancer research initiative.
Image source: Getty Images.
The National Institutes of Health (NIH) plans to begin a campaign to fast-track cancer treatment research in December, according to a report by The New York Times. The program hopes to replicate the success of efforts to develop Covid-19 vaccines during the early stages of the pandemic.
Source: www.fool.com — article syndicated from the publisher’s feed; all rights remain with the original publisher.